Market Cap 291.50M
Revenue (ttm) 12.14M
Net Income (ttm) -99.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -819.60%
Debt to Equity Ratio 0.00
Volume 399,800
Avg Vol 414,966
Day's Range N/A - N/A
Shares Out 79.65M
Stochastic %K 61%
Beta 1.00
Analysts Strong Sell
Price Target $8.00

Company Profile

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing JAK2V617F, a driver mutation product for the treatment of myeloproliferative neoplasms, myelofibrosis (MF), polycythemia vera, and essential thrombocythemia (ET); KAT6A for the treatment of advanced breast cancer and other solid tumors; and mutated calreticulin degrader antibody conjugates to treat M...

Industry: Biotechnology
Sector: Healthcare
Phone: 302 467 1280
Address:
175 Innovation Boulevard, Wilmington, United States
exp8triot
exp8triot Jun. 4 at 2:31 PM
$PRLD I won't become a believer in this until its past $10
0 · Reply
Trader1141
Trader1141 Jun. 4 at 10:33 AM
$STI $MLEC $PRLD $AUUD 🔥 🔥🔥🔥🔥🔥🔥
1 · Reply
trad0r83
trad0r83 Jun. 1 at 2:08 PM
$PRLD Very promising!
0 · Reply
exp8triot
exp8triot May. 22 at 2:34 PM
$PRLD this stock sucks pumpndump scheme here.
2 · Reply
LabPsycho
LabPsycho May. 21 at 8:14 PM
$PRLD @Jaybird827 read between the lines... https://preludetx.com/wp-content/uploads/2026/04/AACR-2026-Prelude-Poster-5793-Final.pdf
3 · Reply
elitechrisvp
elitechrisvp May. 6 at 4:31 PM
$IBRX nice moves $SLS $PRLD
0 · Reply
Jaybird827
Jaybird827 May. 6 at 12:25 AM
$PRLD we need some news
2 · Reply
LabPsycho
LabPsycho Apr. 30 at 8:54 PM
$PRLD I note in their poster PRLD using WuXi AppTech (as did ERAS - check the recent news). Makes me wonder if, over the next year PRLD could be like carbon copy of ERAS move the past the past 5 months. 🤷‍♀️ "Acknowledgments: This study was funded by Prelude Therapeutics Incorporated. Data provided by CrownBio Sciences, WuXi AppTech, Pharmaron, Discovery Life Sciences, IQ Proteomics, and Novogene."
0 · Reply
BioRich
BioRich Apr. 30 at 7:56 PM
$SLS $ALT should have bought $PRLD instead. I''ve made 24% in less than 24 hours. Not bad. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems (like $PRLD and $KYTX) and learn. Let's make some (more) money. Cheers! $XBI
0 · Reply
BioRich
BioRich Apr. 30 at 6:53 PM
$PRLD Thanks to a colleague for putting this on on my radar. Caught a dip yesterday at $4.18 and started a position. Looking good so far. Let's see how this plays out. I'm happy with the 18% 24-hour bump. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn (several tickers I eventually follow are shared with me by colleagues and/or followers). Let's make some (more) money. Cheers!
0 · Reply
Latest News on PRLD
Prelude Therapeutics reports Q1 EPS (13c), consensus (27c)

2026-05-12T11:55:16.000Z - 23 days ago

Prelude Therapeutics reports Q1 EPS (13c), consensus (27c)


Prelude Therapeutics Earnings release: Q1 2026

May 12, 2026, 7:00 AM EDT - 23 days ago

Prelude Therapeutics Earnings release: Q1 2026


Prelude Therapeutics Quarterly report: Q1 2026

May 12, 2026, 7:00 AM EDT - 23 days ago

Prelude Therapeutics Quarterly report: Q1 2026


Prelude Therapeutics Slides: Corporate presentation

May 11, 2026, 7:00 AM EDT - 24 days ago

Prelude Therapeutics Slides: Corporate presentation


Prelude Therapeutics initiated with a Buy at D. Boral Capital

2026-05-04T11:35:31.000Z - 4 weeks ago

Prelude Therapeutics initiated with a Buy at D. Boral Capital


Prelude Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

Prelude Therapeutics Proxy statement: Proxy filing


Prelude Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

Prelude Therapeutics Proxy statement: Proxy filing


Prelude Therapeutics Slides: Corporate presentation

Apr 20, 2026, 7:00 AM EDT - 6 weeks ago

Prelude Therapeutics Slides: Corporate presentation


Prelude Therapeutics management to meet with Citizens

2026-03-18T18:55:15.000Z - 2 months ago

Prelude Therapeutics management to meet with Citizens


Prelude Therapeutics Transcript: Conference

Mar 10, 2026, 3:25 PM EDT - 3 months ago

Prelude Therapeutics Transcript: Conference


Prelude Therapeutics Annual report: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 3 months ago

Prelude Therapeutics Annual report: Q4 2025


Prelude Therapeutics Earnings release: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 3 months ago

Prelude Therapeutics Earnings release: Q4 2025


Prelude Therapeutics sees cash runway into 2Q27

2026-03-10T11:10:14.000Z - 3 months ago

Prelude Therapeutics sees cash runway into 2Q27


Prelude Therapeutics Slides: Corporate presentation

Mar 9, 2026, 7:00 AM EDT - 3 months ago

Prelude Therapeutics Slides: Corporate presentation


Prelude Therapeutics Registration statement: Registration Filing

Dec 10, 2025, 7:00 AM EST - 6 months ago

Prelude Therapeutics Registration statement: Registration Filing


Prelude Therapeutics Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:00 AM EST - 7 months ago

Prelude Therapeutics Earnings Call Transcript: Q3 2025


Prelude Therapeutics Quarterly report: Q3 2025

Nov 12, 2025, 8:00 AM EST - 7 months ago

Prelude Therapeutics Quarterly report: Q3 2025


Prelude Therapeutics Earnings release: Q3 2025

Nov 12, 2025, 8:00 AM EST - 7 months ago

Prelude Therapeutics Earnings release: Q3 2025


Prelude Therapeutics reports Q3 EPS (26c) vs. (43c) last year

2025-11-12T12:22:24.000Z - 7 months ago

Prelude Therapeutics reports Q3 EPS (26c) vs. (43c) last year


Prelude Therapeutics sees cash runway into 2027

2025-11-12T12:22:00.000Z - 7 months ago

Prelude Therapeutics sees cash runway into 2027


Prelude Therapeutics sees cash runway into 2027

2025-11-04T12:35:31.000Z - 7 months ago

Prelude Therapeutics sees cash runway into 2027


Prelude Therapeutics Announces Strategic Business Update

Nov 4, 2025, 7:05 AM EST - 7 months ago

Prelude Therapeutics Announces Strategic Business Update


Prelude Therapeutics Slides: Corporate Presentation

Nov 3, 2025, 7:00 AM EST - 7 months ago

Prelude Therapeutics Slides: Corporate Presentation


Prelude Therapeutics Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 10 months ago

Prelude Therapeutics Quarterly report: Q2 2025


Prelude Therapeutics Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 10 months ago

Prelude Therapeutics Earnings release: Q2 2025


Prelude Therapeutics Quarterly report: Q1 2025

May 6, 2025, 4:00 PM EDT - 1 year ago

Prelude Therapeutics Quarterly report: Q1 2025


Prelude Therapeutics Earnings release: Q1 2025

May 6, 2025, 4:00 PM EDT - 1 year ago

Prelude Therapeutics Earnings release: Q1 2025


Prelude Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Prelude Therapeutics Proxy statement: Proxy Filing


Prelude Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Prelude Therapeutics Proxy statement: Proxy Filing


Prelude Announces Presentations at 2025 AACR Annual Meeting

Apr 25, 2025, 4:05 PM EDT - 1 year ago

Prelude Announces Presentations at 2025 AACR Annual Meeting


Prelude Therapeutics Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Prelude Therapeutics Proxy statement: Proxy Filing


Prelude Therapeutics Annual report: Q4 2024

Mar 10, 2025, 7:00 AM EDT - 1 year ago

Prelude Therapeutics Annual report: Q4 2024


Prelude Therapeutics Earnings release: Q4 2024

Mar 10, 2025, 7:00 AM EDT - 1 year ago

Prelude Therapeutics Earnings release: Q4 2024


Prelude Therapeutics Quarterly report: Q3 2024

Nov 5, 2024, 6:00 PM EST - 1 year ago

Prelude Therapeutics Quarterly report: Q3 2024


Prelude Therapeutics Earnings release: Q3 2024

Nov 5, 2024, 6:00 PM EST - 1 year ago

Prelude Therapeutics Earnings release: Q3 2024


Prelude Therapeutics Transcript: Study Update

Sep 13, 2024, 12:00 PM EDT - 1 year ago

Prelude Therapeutics Transcript: Study Update


Prelude Therapeutics Press release: Study Update

Sep 13, 2024, 12:00 PM EDT - 1 year ago

Prelude Therapeutics Press release: Study Update


Prelude Therapeutics Slides: Study Update

Sep 13, 2024, 12:00 PM EDT - 1 year ago

Prelude Therapeutics Slides: Study Update


Prelude Therapeutics Quarterly report: Q2 2024

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Prelude Therapeutics Quarterly report: Q2 2024


Prelude Therapeutics Earnings release: Q2 2024

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Prelude Therapeutics Earnings release: Q2 2024


Prelude Therapeutics Quarterly report: Q1 2024

May 7, 2024, 7:00 AM EDT - 2 years ago

Prelude Therapeutics Quarterly report: Q1 2024


Prelude Therapeutics Earnings release: Q1 2024

May 7, 2024, 7:00 AM EDT - 2 years ago

Prelude Therapeutics Earnings release: Q1 2024


Prelude Therapeutics Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Prelude Therapeutics Proxy statement: Proxy Filing


Prelude Therapeutics Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Prelude Therapeutics Proxy statement: Proxy Filing


Prelude Therapeutics Annual report: Q4 2023

Feb 15, 2024, 4:30 PM EST - 2 years ago

Prelude Therapeutics Annual report: Q4 2023


Prelude Therapeutics Earnings release: Q4 2023

Feb 15, 2024, 4:30 PM EST - 2 years ago

Prelude Therapeutics Earnings release: Q4 2023


Prelude Therapeutics Announces $25 Million Private Placement

Dec 11, 2023, 9:34 AM EST - 2 years ago

Prelude Therapeutics Announces $25 Million Private Placement


Prelude Therapeutics Quarterly report: Q3 2023

Nov 1, 2023, 4:00 PM EDT - 2 years ago

Prelude Therapeutics Quarterly report: Q3 2023


Prelude Therapeutics Earnings release: Q3 2023

Nov 1, 2023, 4:00 PM EDT - 2 years ago

Prelude Therapeutics Earnings release: Q3 2023


Prelude Therapeutics Quarterly report: Q2 2023

Aug 3, 2023, 7:00 AM EDT - 3 years ago

Prelude Therapeutics Quarterly report: Q2 2023


Prelude Therapeutics Earnings release: Q2 2023

Aug 3, 2023, 7:00 AM EDT - 3 years ago

Prelude Therapeutics Earnings release: Q2 2023


Prelude Therapeutics Quarterly report: Q1 2023

May 8, 2023, 7:00 AM EDT - 3 years ago

Prelude Therapeutics Quarterly report: Q1 2023


Prelude Therapeutics Earnings release: Q1 2023

May 8, 2023, 7:00 AM EDT - 3 years ago

Prelude Therapeutics Earnings release: Q1 2023


Prelude Therapeutics Proxy statement: Proxy Filing

Apr 28, 2023, 8:00 AM EDT - 3 years ago

Prelude Therapeutics Proxy statement: Proxy Filing


Prelude Therapeutics Proxy statement: Proxy Filing

Apr 28, 2023, 8:00 AM EDT - 3 years ago

Prelude Therapeutics Proxy statement: Proxy Filing


Prelude Therapeutics Proxy statement: Proxy Filing

Apr 18, 2023, 8:00 AM EDT - 3 years ago

Prelude Therapeutics Proxy statement: Proxy Filing


Prelude Therapeutics Annual report: Q4 2022

Mar 15, 2023, 8:00 AM EDT - 3 years ago

Prelude Therapeutics Annual report: Q4 2022


Prelude Therapeutics Earnings release: Q4 2022

Mar 15, 2023, 8:00 AM EDT - 3 years ago

Prelude Therapeutics Earnings release: Q4 2022


exp8triot
exp8triot Jun. 4 at 2:31 PM
$PRLD I won't become a believer in this until its past $10
0 · Reply
Trader1141
Trader1141 Jun. 4 at 10:33 AM
$STI $MLEC $PRLD $AUUD 🔥 🔥🔥🔥🔥🔥🔥
1 · Reply
trad0r83
trad0r83 Jun. 1 at 2:08 PM
$PRLD Very promising!
0 · Reply
exp8triot
exp8triot May. 22 at 2:34 PM
$PRLD this stock sucks pumpndump scheme here.
2 · Reply
LabPsycho
LabPsycho May. 21 at 8:14 PM
$PRLD @Jaybird827 read between the lines... https://preludetx.com/wp-content/uploads/2026/04/AACR-2026-Prelude-Poster-5793-Final.pdf
3 · Reply
elitechrisvp
elitechrisvp May. 6 at 4:31 PM
$IBRX nice moves $SLS $PRLD
0 · Reply
Jaybird827
Jaybird827 May. 6 at 12:25 AM
$PRLD we need some news
2 · Reply
LabPsycho
LabPsycho Apr. 30 at 8:54 PM
$PRLD I note in their poster PRLD using WuXi AppTech (as did ERAS - check the recent news). Makes me wonder if, over the next year PRLD could be like carbon copy of ERAS move the past the past 5 months. 🤷‍♀️ "Acknowledgments: This study was funded by Prelude Therapeutics Incorporated. Data provided by CrownBio Sciences, WuXi AppTech, Pharmaron, Discovery Life Sciences, IQ Proteomics, and Novogene."
0 · Reply
BioRich
BioRich Apr. 30 at 7:56 PM
$SLS $ALT should have bought $PRLD instead. I''ve made 24% in less than 24 hours. Not bad. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems (like $PRLD and $KYTX) and learn. Let's make some (more) money. Cheers! $XBI
0 · Reply
BioRich
BioRich Apr. 30 at 6:53 PM
$PRLD Thanks to a colleague for putting this on on my radar. Caught a dip yesterday at $4.18 and started a position. Looking good so far. Let's see how this plays out. I'm happy with the 18% 24-hour bump. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn (several tickers I eventually follow are shared with me by colleagues and/or followers). Let's make some (more) money. Cheers!
0 · Reply
1AMBITIOUSSAVAGE
1AMBITIOUSSAVAGE Apr. 30 at 6:17 PM
$PRLD $AKAN NWGL - somethingcooking HOLD
0 · Reply
elitechrisvp
elitechrisvp Apr. 30 at 6:10 PM
$IBRX and $SLS and $PRLD dood stuff ✅️👍
0 · Reply
LabPsycho
LabPsycho Apr. 29 at 5:19 PM
$PRLD @BillionerOfKing The problem I see with this strategy is you are not taking into account the enourmous spreads in many of these biotech options. The stock would have to move +/-80% before you broke even.
0 · Reply
LabPsycho
LabPsycho Apr. 29 at 5:11 PM
$PRLD @chole1 I wonder if the ERAS situation the past few days has thrown a wet blanket on biotech companies doing protein degraders / glues, etc?
0 · Reply
BillionerOfKing
BillionerOfKing Apr. 28 at 2:26 PM
$PRLD Current Stock Price: $4.54 Contracts to trade: $5.0 PRLD May 15 2026 Call Entry: $0.15 Exit: $0.25 ROI: 66% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DARKP00L
DARKP00L Apr. 27 at 11:59 AM
$PRLD 07:57 on Apr. 27 2026 HC Wainwright & Co. Maintains Buy on Prelude Therapeutics, Raises Price Target to $8 #tradeideas
0 · Reply
chole1
chole1 Apr. 27 at 11:51 AM
$PRLD LLY buying private company Ajax Therapeutics for up to USD 2.3bn, for yet anothe Jak2i... Lets go PRLD!
0 · Reply
vu_jade
vu_jade Apr. 24 at 7:34 PM
$PRLD Top two holders: Orbimed Baker Brothers Couple of retards
0 · Reply
Jaybird827
Jaybird827 Apr. 24 at 2:58 PM
$PRLD with all these shares being bought, how many shares can be remaining?
0 · Reply
kubota2323
kubota2323 Apr. 24 at 2:33 PM
$PRLD https://www.sec.gov/Archives/edgar/data/1678660/000094787126000461/xslF345X03/ownership.xml
0 · Reply
kubota2323
kubota2323 Apr. 24 at 2:27 PM
$PRLD Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4 Bonita David P Director Apr 21 '26 Buy 4.44 2,815,315 12,499,999 11,808,945 Apr 23 06:50 PM ORBIMED ADVISORS LLC Director Apr 21 '26 Buy 4.44 2,815,315 12,499,999 11,808,945 Apr 23 06:48 PM open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
0 · Reply
Biotech_Pharma_Investor
Biotech_Pharma_Investor Apr. 24 at 6:23 AM
$PRLD btw less partnerships is not necesarily a disantantage It could mean; (1) cleaner acquisition target (2) room for new partnerships while PRLD is at strentgh It could also mean that potential partners preferred other degrader companies. But this feels unlikely given the way PRLD is trading, recent PIPE and strong involvement by biotech specialists institutions. @LabPsycho
1 · Reply